On Cancer

Filter by Tag

In the Lab

New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective

By Julie Grisham, MS, Science Writer/Editor | Tuesday, December 18, 2012

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Tags: Cell Therapy; Immunotherapy; Immunology; Research

Pictured: Isabelle Rivière and Michel Sadelain

In the Clinic

Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

By Julie Grisham, MS, Science Writer/Editor | Monday, July 16, 2012

Memorial Sloan-Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.

Tags: Cancer Care; Clinical Trials; Cell Engineering; Cell Therapy; Research

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

Feature

Cell-Based Therapies Show Promise

By Julie Grisham, MS, Science Writer/Editor | Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Tags: Cell Engineering; Cell Therapy; Immunotherapy; Drug Discovery; Experimental Therapeutics; Research